Table 4 Cardiovascular outcome

arterial hypertension posttransplant, n

39 (93%)

20 (95%)

0.715

MAD in mmHG

 pretransplant

101.2 ± 10.9

96.3 ± 11.1

0.09

 follow-up 1 year

91.6 ± 5.4

˂0.005

98.7 ± 9.1

0.161

0.001

 follow-up 3 years

90.8 ± 10.7

 < 0.005

100.1 ± 5.2

0.06

0.001

 follow-up 5 years

88.9 ± 11.8

 < 0.005

101.4 ± 3.2

0.01

0.001

Number of antihypertensive medications, n

2.67 ± 1.7

2,29 ± 1.8

 > 3 antihypertensive medications, n

12 (28%)

5 (23%)

0.788

Cardiovascular events post-transplant

3 (7%)

5 (23%)

0.05

 myocardial infarction

2 (4.7%)

2 (19%)

0.464

 Percutaneous coronary

1 (2.3%)

3 (13%)

0.067

 intervention

 Coronary artery bypass

0

0

1.0

Cerebrovascular accident posttransplant

1 (2.4%)

3 (14.3%)

0.06

Statin at follow-up

17 (42%)

13 (61%)

0.048

Aspirin at follow-up

26 (62%)

15 (71%)

0.045